ConductScience.org, home

Paper39831789

The fluoroquinolone compounds potentiate the antifungal activity of the echinocandins against Aspergillus fumigatus.

Choi JJ and 8 others. Biosci Rep, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. The fluoroquinolone compounds potentiate the antifungal activity of the echinocandins against Aspergillus fumigatus. Papers, record 39831789. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39831789

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The fluoroquinolone compounds potentiate the antifungal activity of the echinocandins against Aspergillus fumigatus.
PubMed
Journal
Biosci Rep
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2025-07-10
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Choi JJJin-Ju
2Kang SSuzie
3Lee YYoonseo
4Lee DHDong-Hyun
5Jang YYuju
6Goo JIJa-Il
7Choi YYongseok
8Lee DDongho
9Yun CWCheol-Wonhttps://orcid.org/0000-0002-0697-4768

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Aspergillus fumigatusMajor topic
Antifungal AgentsMajor topic
FluoroquinolonesMajor topic
EchinocandinsMajor topic
AspergillosisMajor topic
Animals
Drug Synergism
Mice
Caspofungin
Drug Resistance, Fungal
Microbial Sensitivity Tests
Humans
Ergosterol
Molecular Docking Simulation
Fungal Proteins

Source PubMed

Download CSV of topics

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13111257Norfloxacin, a fluoroquinolone antibacterial agent. Classification, mechanism of action, and in vitro activity.Am J Med1987https://conductscience.org/library/papers/3111257PubMed
27516863Levofloxacin. A review of its antibacterial activity, pharmacokinetics and therapeutic efficacy.Drugs1994https://conductscience.org/library/papers/7516863PubMed
328702763Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.Infection2017https://conductscience.org/library/papers/28702763PubMed
421486730Pharmacology and metabolism of anidulafungin, caspofungin and micafungin in the treatment of invasive candidosis: review of the literature.Eur J Med Res2011https://conductscience.org/library/papers/21486730PubMed
527927037Clinical hepatotoxicity associated with antifungal agents.Expert Opin Drug Saf2017https://conductscience.org/library/papers/27927037PubMed
615375111Combinations of antifungal agents in therapy--what value are they?J Antimicrob Chemother2004https://conductscience.org/library/papers/15375111PubMed
710508721Mechanism of fluoroquinolone action.Curr Opin Microbiol1999https://conductscience.org/library/papers/10508721PubMed
827379235Recognition of Membrane Sterols by Polyene Antifungals Amphotericin B and Natamycin, A (13)C MAS NMR Study.Front Cell Dev Biol2016https://conductscience.org/library/papers/27379235PubMed
929773744Worldwide emergence of resistance to antifungal drugs challenges human health and food security.Science2018https://conductscience.org/library/papers/29773744PubMed
1028258218Structural analyses of Candida albicans sterol 14α-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis.J Biol Chem2017https://conductscience.org/library/papers/28258218PubMed
1131021468Quinolone derivatives and their antifungal activities: An overview.Arch Pharm (Weinheim)2019https://conductscience.org/library/papers/31021468PubMed
1226684607Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial.Lancet2016https://conductscience.org/library/papers/26684607PubMed
1323550668Combination antifungal therapy for cryptococcal meningitis.N Engl J Med2013https://conductscience.org/library/papers/23550668PubMed
1417569573Resistance to echinocandin-class antifungal drugs.Drug Resist Updat2007https://conductscience.org/library/papers/17569573PubMed
1524715154Emergence of echinocandin-resistant Candida spp. in a hospital setting: a consequence of 10 years of increasing use of antifungal therapy?Eur J Clin Microbiol Infect Dis2014https://conductscience.org/library/papers/24715154PubMed
163292209Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.Drugs1988https://conductscience.org/library/papers/3292209PubMed
1726908577The Aspergillus fumigatus Damage Resistance Protein Family Coordinately Regulates Ergosterol Biosynthesis and Azole Susceptibility.mBio2016https://conductscience.org/library/papers/26908577PubMed
1815578352Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy.Clin Infect Dis2004https://conductscience.org/library/papers/15578352PubMed
1927381395Aspergillus fumigatus Intrinsic Fluconazole Resistance Is Due to the Naturally Occurring T301I Substitution in Cyp51Ap.Antimicrob Agents Chemother2016https://conductscience.org/library/papers/27381395PubMed
2016989123[Emerging azole antifungals].Therapie2006https://conductscience.org/library/papers/16989123PubMed

See all 42 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39831789

GET https://conductscience.org/api/papers/v1/39831789/references?page=2